Price Monitoring Reveals Strong Inflation And Breaches Of Limits

Pharmaceutical prices in Russia and Ukraine have been under intense scrutiny since the latter part of 2008, as a result of negative economic conditions, associated currency devaluations and profiteering within the supply chain. Sharp rises in pharmaceutical prices caused the respective governments' antimonopoly committees and Ministries of Health to monitor prices. Results from these surveys suggest that concerns were, in some cases,

To read the full article, please choose one of the following options: